Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation.
Mutations in GBA (glucosylceramidase beta), which encodes the lysosomal enzyme glucocerebrosidase (GCase), are the strongest genetic risk factor for the neurodegenerative disorders Parkinson's disease (PD) and Lewy body dementia. Recent work has suggested that neuroinflammation may be an import...
Saved in:
| Main Authors: | Evelyn S Vincow, Ruth E Thomas, Gillian Milstein, Gautam Pareek, Theo K Bammler, James MacDonald, Leo J Pallanck |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-11-01
|
| Series: | PLoS Genetics |
| Online Access: | https://doi.org/10.1371/journal.pgen.1011105 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of Recombinant Human Glucocerebrosidase Protein in Sunflowers
by: Al-Dallee et al.
Published: (2019-03-01) -
Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?
by: Vijitha Senanayake, et al.
Published: (2019-01-01) -
Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function
by: Thomas Dal Maso, et al.
Published: (2025-05-01) -
Base and translation of β-glucocerebrosidase and its transporter LIMP-2 in neuropathies
by: Philipp Arnold, et al.
Published: (2026-01-01) -
Relationship of cognitive decline with glucocerebrosidase activity and amyloid‐beta 42 in DLB and PD
by: Maria Camila Gonzalez, et al.
Published: (2025-05-01)